Cas No.: 250612-42-1
PRODUCT INFORMATION
Description
Cyclo(RGDyK) is a powerful and selective inhibitor of the αVβ3 integrin. Its potency is well-documented, with a reported IC50 of 20 nM. This peptide is widely used in biomedical research as a tool to block integrin-mediated cell adhesion and signaling, and as a targeting moiety for conjugation to nanoparticles or imaging agents.
Molecular Weight
847.72
Purity
> 95%
Formula
C₃₁H₄₃F₆N₉O₁₂
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Tyr-Lys]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA Targeting Peptide (CAT#: OLY-1025-YS-51)
- F3 Targeting Peptide (CAT#: OLY-1025-YS-28)
- CGGRGD Targeting Peptide (CAT#: OLY-1025-YS-26)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- NGR Targeting Peptide (CAT#: OLY-1025-YS-38)
- Cyclo(RGDfK(Mal)) Targeting Peptide (CAT#: OLY-1025-YS-46)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.